Deutsche Bank Ag\ Biomarin Pharmaceutical Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 1,546,167 shares of BMRN stock, worth $104 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares

1,546,167

Previous 1,807,032 14.44%

Holding current value

$104 Million

Previous $149 Million 26.95%

% of portfolio

0.05%

Previous 0.07%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$69.02 - $93.84 $18 Million - $24.5 Million	-260,865 Reduced 14.44%	1,546,167 $109 Million
Q2 2024 Aug 14, 2024	SELL	$74.43 - $92.22 $39.6 Million - $49.1 Million	-532,204 Reduced 22.75%	1,807,032 $149 Million
Q1 2024 May 15, 2024	SELL	$83.81 - $99.0 $89.1 Million - $105 Million	-1,062,961 Reduced 31.24%	2,339,236 $204 Million
Q4 2023 Feb 14, 2024	BUY	$76.22 - $98.51 $153 Million - $197 Million	2,003,478 Added 143.24%	3,402,197 $328 Million
Q3 2023 Nov 09, 2023	SELL	$85.07 - $94.48 $50.7 Million - $56.3 Million	-596,287 Reduced 29.89%	1,398,719 $124 Million
Q2 2023 Aug 14, 2023	SELL	$86.68 - $100.3 $8.82 Million - $10.2 Million	-101,769 Reduced 4.85%	1,995,006 $173 Million
Q1 2023 May 15, 2023	SELL	$87.74 - $117.27 $25.6 Million - $34.2 Million	-291,991 Reduced 12.22%	2,096,775 $204 Million
Q4 2022 Feb 13, 2023	BUY	$80.93 - $108.63 $14.2 Million - $19 Million	175,192 Added 7.91%	2,388,766 $247 Million
Q3 2022 Nov 14, 2022	BUY	$82.16 - $96.94 $81.1 Million - $95.7 Million	986,996 Added 80.47%	2,213,574 $188 Million
Q2 2022 Aug 11, 2022	BUY	$71.48 - $86.85 $24 Million - $29.1 Million	335,397 Added 37.64%	1,226,578 $102 Million
Q1 2022 May 13, 2022	SELL	$74.28 - $92.69 $3.71 Million - $4.63 Million	-49,914 Reduced 5.3%	891,181 $68.7 Million
Q4 2021 Feb 11, 2022	BUY	$71.72 - $91.47 $3.46 Million - $4.41 Million	48,216 Added 5.4%	941,095 $83.1 Million
Q3 2021 Nov 04, 2021	SELL	$74.77 - $85.47 $21.2 Million - $24.3 Million	-284,012 Reduced 24.13%	892,879 $69 Million
Q2 2021 Aug 11, 2021	BUY	$75.51 - $84.79 $2.93 Million - $3.29 Million	38,800 Added 3.41%	1,176,891 $98.2 Million
Q1 2021 May 13, 2021	BUY	$74.73 - $90.69 $5.96 Million - $7.23 Million	79,716 Added 7.53%	1,138,091 $85.9 Million
Q4 2020 Feb 16, 2021	SELL	$72.61 - $90.2 $22.9 Million - $28.4 Million	-315,173 Reduced 22.95%	1,058,375 $92.8 Million
Q3 2020 Nov 12, 2020	SELL	$71.87 - $131.03 $8.52 Million - $15.5 Million	-118,508 Reduced 7.94%	1,373,548 $104 Million
Q2 2020 Aug 13, 2020	BUY	$79.55 - $124.22 $695,505 - $1.09 Million	8,743 Added 0.59%	1,492,056 $184 Million
Q1 2020 May 14, 2020	BUY	$71.37 - $96.85 $13 Million - $17.6 Million	182,136 Added 14.0%	1,483,313 $125 Million
Q4 2019 Feb 14, 2020	BUY	$64.27 - $86.37 $5.39 Million - $7.25 Million	83,891 Added 6.89%	1,301,177 $110 Million
Q3 2019 Nov 14, 2019	SELL	$67.4 - $85.11 $24.6 Million - $31.1 Million	-365,106 Reduced 23.07%	1,217,286 $82 Million
Q2 2019 Aug 14, 2019	BUY	$80.35 - $93.9 $15.2 Million - $17.8 Million	189,620 Added 13.61%	1,582,392 $136 Million
Q1 2019 May 15, 2019	BUY	$84.2 - $98.62 $41.6 Million - $48.8 Million	494,511 Added 55.05%	1,392,772 $124 Million
Q4 2018 Feb 14, 2019	SELL	$80.14 - $106.07 $26.5 Million - $35.1 Million	-330,575 Reduced 26.9%	898,261 $76.5 Million
Q3 2018 Dec 21, 2021	BUY	$93.92 - $105.72 $22.4 Million - $25.2 Million	238,282 Added 24.06%	1,228,836 $119 Million
Q3 2018 Nov 14, 2018	SELL	$93.92 - $105.72 $12.7 Million - $14.3 Million	-135,536 Reduced 12.04%	990,554 $96 Million
Q2 2018 Apr 21, 2020	BUY	$76.01 - $99.03 $10.8 Million - $14 Million	141,856 Added 14.41%	1,126,090 $106 Million
Q2 2018 Aug 14, 2018	SELL	$76.01 - $99.03 $20 Million - $26.1 Million	-263,715 Reduced 21.13%	984,234 $92.7 Million
Q1 2018 Oct 18, 2019	BUY	$77.67 - $92.63 $11.4 Million - $13.6 Million	146,556 Added 13.31%	1,247,949 $101 Million
Q1 2018 May 15, 2018	BUY	$77.67 - $92.63 $5.52 Million - $6.59 Million	71,091 Added 6.9%	1,101,393 $89.3 Million
Q4 2017 Feb 14, 2018	SELL	$80.76 - $95.13 $29.2 Million - $34.4 Million	-361,778 Reduced 25.99%	1,030,302 $91.9 Million
Q3 2017 Nov 14, 2017	BUY	$80.6 - $94.95 $112 Million - $132 Million	1,392,080	1,392,080 $130 Million

Others Institutions Holding BMRN

# of Institutions

638

Shares Held

178M

Call Options Held

2.01M

Put Options Held

1.28M

View Full List

About BIOMARIN PHARMACEUTICAL INC

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.5B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

More about BMRN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account